MP Materials Reports Third Quarter 2024 Results
Revenue increased 20% year-over-year to
Record REO production of 13,742 metric tons, a 28% increase year-over-year
Record NdPr production of 478 metric tons, a 76% sequential increase
NdPr sales volumes nearly tripled sequentially to 404 metric tons
“The MP team delivered record production of rare earth concentrate and NdPr oxide in the third quarter,” said
Third Quarter 2024 Financial and Operational Highlights
|
For the three months ended
|
|
2024 vs. 2023 |
|||||||||||
(unaudited) |
2024 |
|
2023 |
|
Amount Change |
|
% Change |
|||||||
Financial Measures: |
(in thousands, except per share data) |
|
|
|||||||||||
Revenue |
$ |
62,927 |
|
|
$ |
52,516 |
|
|
$ |
10,411 |
|
|
20 |
% |
Net loss |
$ |
(25,516 |
) |
|
$ |
(4,276 |
) |
|
$ |
(21,240 |
) |
|
497 |
% |
Adjusted EBITDA(1) |
$ |
(11,168 |
) |
|
$ |
15,551 |
|
|
$ |
(26,719 |
) |
|
N/M |
|
Adjusted Net Income (Loss)(1) |
$ |
(19,634 |
) |
|
$ |
7,026 |
|
|
$ |
(26,660 |
) |
|
N/M |
|
Diluted EPS |
$ |
(0.16 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.14 |
) |
|
700 |
% |
Adjusted Diluted EPS(1) |
$ |
(0.12 |
) |
|
$ |
0.04 |
|
|
$ |
(0.16 |
) |
|
N/M |
|
|
|
|
|
|
|
|
|
|||||||
Key Performance Indicators: |
|
|
|
|
|
|
|
|||||||
Rare earth concentrate |
(in whole units or dollars) |
|
|
|||||||||||
REO Production Volume (MTs) |
|
13,742 |
|
|
|
10,766 |
|
|
|
2,976 |
|
|
28 |
% |
REO Sales Volume (MTs) |
|
9,729 |
|
|
|
9,177 |
|
|
|
552 |
|
|
6 |
% |
Realized Price per REO MT |
$ |
4,425 |
|
|
$ |
5,718 |
|
|
$ |
(1,293 |
) |
|
(23 |
)% |
Separated NdPr products |
|
|
|
|
|
|
|
|||||||
NdPr Production Volume (MTs) |
|
478 |
|
|
|
50 |
|
|
|
428 |
|
|
856 |
% |
NdPr Sales Volume (MTs) |
|
404 |
|
|
|
— |
|
|
|
404 |
|
|
N/A |
|
NdPr Realized Price per KG |
$ |
47 |
|
|
|
N/A |
|
|
N/A |
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|||||||
N/M = Not meaningful. |
||||||||||||||
N/A = Not applicable as there was no sales volume during the three months ended |
(1) |
See “Use of Non-GAAP Financial Measures” below for the definitions of Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Diluted EPS. See tables below for reconciliations of non-GAAP financial measures to their most directly comparable GAAP financial measures. |
Revenue increased 20% year-over-year to
Adjusted EBITDA declined by
Adjusted Net Income (Loss) decreased by
Net income (loss) decreased by
Diluted earnings per share (“EPS”) decreased by
|
|||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
|
|
|
|
||||
(in thousands, except share and per share data, unaudited) |
2024 |
|
2023 |
||||
Assets |
|
|
|
||||
Current assets |
|
|
|
||||
Cash and cash equivalents |
$ |
284,434 |
|
|
$ |
263,351 |
|
Short-term investments |
|
582,056 |
|
|
|
734,493 |
|
Total cash, cash equivalents and short-term investments |
|
866,490 |
|
|
|
997,844 |
|
Accounts receivable |
|
14,549 |
|
|
|
10,029 |
|
Inventories |
|
116,699 |
|
|
|
95,182 |
|
Government grant receivable |
|
7,846 |
|
|
|
19,302 |
|
Prepaid expenses and other current assets |
|
11,599 |
|
|
|
8,820 |
|
Total current assets |
|
1,017,183 |
|
|
|
1,131,177 |
|
Non-current assets |
|
|
|
||||
Property, plant and equipment, net |
|
1,230,517 |
|
|
|
1,158,054 |
|
Operating lease right-of-use assets |
|
9,004 |
|
|
|
10,065 |
|
Inventories |
|
19,825 |
|
|
|
13,350 |
|
Equity method investment |
|
8,962 |
|
|
|
9,673 |
|
Intangible assets, net |
|
7,970 |
|
|
|
8,881 |
|
Other non-current assets |
|
6,825 |
|
|
|
5,252 |
|
Total non-current assets |
|
1,283,103 |
|
|
|
1,205,275 |
|
Total assets |
$ |
2,300,286 |
|
|
$ |
2,336,452 |
|
Liabilities and stockholders’ equity |
|
|
|
||||
Current liabilities |
|
|
|
||||
Accounts and construction payable |
$ |
21,711 |
|
|
$ |
27,995 |
|
Accrued liabilities |
|
66,224 |
|
|
|
73,939 |
|
Deferred revenue |
|
50,000 |
|
|
|
— |
|
Other current liabilities |
|
8,854 |
|
|
|
6,616 |
|
Total current liabilities |
|
146,789 |
|
|
|
108,550 |
|
Non-current liabilities |
|
|
|
||||
Asset retirement obligations |
|
5,856 |
|
|
|
5,518 |
|
Environmental obligations |
|
16,506 |
|
|
|
16,545 |
|
Long-term debt, net |
|
937,634 |
|
|
|
681,980 |
|
Operating lease liabilities |
|
6,016 |
|
|
|
6,829 |
|
Deferred government grant |
|
19,836 |
|
|
|
17,433 |
|
Deferred income taxes |
|
98,541 |
|
|
|
130,793 |
|
Other non-current liabilities |
|
4,568 |
|
|
|
3,025 |
|
Total non-current liabilities |
|
1,088,957 |
|
|
|
862,123 |
|
Total liabilities |
|
1,235,746 |
|
|
|
970,673 |
|
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Preferred stock ( |
|
— |
|
|
|
— |
|
Common stock ( |
|
18 |
|
|
|
17 |
|
Additional paid-in capital |
|
948,687 |
|
|
|
979,891 |
|
Retained earnings |
|
342,644 |
|
|
|
385,726 |
|
Accumulated other comprehensive income |
|
296 |
|
|
|
145 |
|
|
|
(227,105 |
) |
|
|
— |
|
Total stockholders’ equity |
|
1,064,540 |
|
|
|
1,365,779 |
|
Total liabilities and stockholders’ equity |
$ |
2,300,286 |
|
|
$ |
2,336,452 |
|
|
|||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
For the three months
ended |
|
For the nine months
ended |
||||||||||||
(in thousands, except share and per share data, unaudited) |
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Revenue: |
|
|
|
|
|
|
|
||||||||
Rare earth concentrate |
$ |
43,053 |
|
|
$ |
52,472 |
|
|
$ |
107,555 |
|
|
$ |
212,139 |
|
NdPr oxide and metal |
|
19,179 |
|
|
|
— |
|
|
|
34,037 |
|
|
|
— |
|
Other revenue |
|
695 |
|
|
|
44 |
|
|
|
1,277 |
|
|
|
101 |
|
Total revenue |
|
62,927 |
|
|
|
52,516 |
|
|
|
142,869 |
|
|
|
212,240 |
|
|
|
|
|
|
|
|
|
||||||||
Operating costs and expenses: |
|
|
|
|
|
|
|
||||||||
Cost of sales (excluding depreciation, depletion and amortization) |
|
57,266 |
|
|
|
22,217 |
|
|
|
134,323 |
|
|
|
69,137 |
|
Selling, general and administrative |
|
21,525 |
|
|
|
19,561 |
|
|
|
64,226 |
|
|
|
57,829 |
|
Depreciation, depletion and amortization |
|
19,344 |
|
|
|
16,751 |
|
|
|
55,939 |
|
|
|
37,076 |
|
Start-up costs |
|
1,627 |
|
|
|
7,336 |
|
|
|
4,287 |
|
|
|
16,125 |
|
Advanced projects and development |
|
2,051 |
|
|
|
2,873 |
|
|
|
8,143 |
|
|
|
9,586 |
|
Other operating costs and expenses |
|
654 |
|
|
|
1,314 |
|
|
|
1,415 |
|
|
|
6,578 |
|
Total operating costs and expenses |
|
102,467 |
|
|
|
70,052 |
|
|
|
268,333 |
|
|
|
196,331 |
|
Operating income (loss) |
|
(39,540 |
) |
|
|
(17,536 |
) |
|
|
(125,464 |
) |
|
|
15,909 |
|
Interest expense, net |
|
(6,646 |
) |
|
|
(1,396 |
) |
|
|
(16,248 |
) |
|
|
(4,147 |
) |
Gain on early extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
46,265 |
|
|
|
— |
|
Other income, net |
|
11,320 |
|
|
|
14,456 |
|
|
|
36,061 |
|
|
|
41,970 |
|
Income (loss) before income taxes |
|
(34,866 |
) |
|
|
(4,476 |
) |
|
|
(59,386 |
) |
|
|
53,732 |
|
Income tax benefit (expense) |
|
9,350 |
|
|
|
200 |
|
|
|
16,304 |
|
|
|
(13,166 |
) |
Net income (loss) |
$ |
(25,516 |
) |
|
$ |
(4,276 |
) |
|
$ |
(43,082 |
) |
|
$ |
40,566 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
(0.16 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.26 |
) |
|
$ |
0.23 |
|
Diluted |
$ |
(0.16 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.44 |
) |
|
$ |
0.22 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
||||||||
Basic |
|
164,149,348 |
|
|
|
177,231,717 |
|
|
|
168,002,773 |
|
|
|
177,034,068 |
|
Diluted |
|
164,149,348 |
|
|
|
177,231,717 |
|
|
|
172,066,214 |
|
|
|
193,632,662 |
|
|
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
|
|
|
||||
|
For the nine months ended
|
||||||
(in thousands, unaudited) |
2024 |
|
2023 |
||||
Operating activities: |
|
|
|||||
Net income (loss) |
$ |
(43,082 |
) |
|
$ |
40,566 |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
|
|
|
||||
Depreciation, depletion and amortization |
|
55,939 |
|
|
|
37,076 |
|
Accretion of discount on short-term investments |
|
(23,669 |
) |
|
|
(17,334 |
) |
Gain on early extinguishment of debt |
|
(46,265 |
) |
|
|
— |
|
Stock-based compensation expense |
|
18,623 |
|
|
|
19,041 |
|
Amortization of debt issuance costs |
|
2,864 |
|
|
|
2,650 |
|
Lower of cost or net realizable value reserve |
|
15,085 |
|
|
|
— |
|
Deferred income taxes |
|
(16,240 |
) |
|
|
13,156 |
|
Other |
|
1,957 |
|
|
|
1,091 |
|
Decrease (increase) in operating assets: |
|
|
|
||||
Accounts receivable |
|
(4,520 |
) |
|
|
19,676 |
|
Inventories |
|
(42,851 |
) |
|
|
(25,498 |
) |
Government grant receivable |
|
11,456 |
|
|
|
— |
|
Prepaid expenses, other current and non-current assets |
|
(2,390 |
) |
|
|
(1,437 |
) |
Increase (decrease) in operating liabilities: |
|
|
|
||||
Accounts payable and accrued liabilities |
|
(1,303 |
) |
|
|
8,601 |
|
Income taxes payable |
|
— |
|
|
|
(21,163 |
) |
Deferred revenue |
|
50,000 |
|
|
|
— |
|
Deferred government grant |
|
4,086 |
|
|
|
— |
|
Other current and non-current liabilities |
|
3,182 |
|
|
|
55 |
|
Net cash provided by (used in) operating activities |
|
(17,128 |
) |
|
|
76,480 |
|
Investing activities: |
|
|
|
||||
Additions to property, plant and equipment |
|
(144,768 |
) |
|
|
(188,927 |
) |
Purchases of short-term investments |
|
(1,150,609 |
) |
|
|
(705,241 |
) |
Proceeds from sales of short-term investments |
|
131,776 |
|
|
|
461,042 |
|
Proceeds from maturities of short-term investments |
|
1,195,202 |
|
|
|
769,907 |
|
Proceeds from government awards used for construction |
|
96 |
|
|
|
1,050 |
|
Net cash provided by investing activities |
|
31,697 |
|
|
|
337,831 |
|
Financing activities: |
|
|
|
||||
Proceeds from issuance of long-term debt |
|
747,500 |
|
|
|
— |
|
Payment of debt issuance costs |
|
(16,149 |
) |
|
|
— |
|
Payments to retire long-term debt |
|
(428,599 |
) |
|
|
— |
|
Purchase of capped call options |
|
(65,332 |
) |
|
|
— |
|
Repurchases of common stock |
|
(225,068 |
) |
|
|
— |
|
Principal payments on debt obligations and finance leases |
|
(1,738 |
) |
|
|
(2,101 |
) |
Tax withholding on stock-based awards |
|
(4,577 |
) |
|
|
(6,476 |
) |
Net cash provided by (used in) financing activities |
|
6,037 |
|
|
|
(8,577 |
) |
Net change in cash, cash equivalents and restricted cash |
|
20,606 |
|
|
|
405,734 |
|
Cash, cash equivalents and restricted cash beginning balance |
|
264,988 |
|
|
|
143,509 |
|
Cash, cash equivalents and restricted cash ending balance |
$ |
285,594 |
|
|
$ |
549,243 |
|
|
|
|
|
||||
Reconciliation of cash, cash equivalents and restricted cash: |
|
|
|
||||
Cash and cash equivalents |
$ |
284,434 |
|
|
$ |
547,668 |
|
Restricted cash, current |
|
811 |
|
|
|
1,228 |
|
Restricted cash, non-current |
|
349 |
|
|
|
347 |
|
Total cash, cash equivalents and restricted cash |
$ |
285,594 |
|
|
$ |
549,243 |
|
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Adjusted EBITDA |
|||||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
For the three months
ended |
|
For the nine months
ended |
||||||||||||
(in thousands, unaudited) |
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Net income (loss) |
$ |
(25,516 |
) |
|
$ |
(4,276 |
) |
|
$ |
(43,082 |
) |
|
$ |
40,566 |
|
Adjusted for: |
|
|
|
|
|
|
|
||||||||
Depreciation, depletion and amortization |
|
19,344 |
|
|
|
16,751 |
|
|
|
55,939 |
|
|
|
37,076 |
|
Interest expense, net |
|
6,646 |
|
|
|
1,396 |
|
|
|
16,248 |
|
|
|
4,147 |
|
Income tax expense (benefit) |
|
(9,350 |
) |
|
|
(200 |
) |
|
|
(16,304 |
) |
|
|
13,166 |
|
Stock-based compensation expense(1) |
|
5,453 |
|
|
|
6,298 |
|
|
|
18,623 |
|
|
|
19,041 |
|
Initial start-up costs(2) |
|
1,493 |
|
|
|
7,082 |
|
|
|
3,918 |
|
|
|
15,474 |
|
Transaction-related and other costs(3) |
|
1,428 |
|
|
|
1,642 |
|
|
|
6,108 |
|
|
|
7,124 |
|
Accretion of asset retirement and environmental obligations(4) |
|
234 |
|
|
|
227 |
|
|
|
695 |
|
|
|
681 |
|
Loss on disposals of long-lived assets, net(4)(5) |
|
420 |
|
|
|
1,087 |
|
|
|
720 |
|
|
|
5,897 |
|
Gain on early extinguishment of debt(6) |
|
— |
|
|
|
— |
|
|
|
(46,265 |
) |
|
|
— |
|
Other income, net(7) |
|
(11,320 |
) |
|
|
(14,456 |
) |
|
|
(36,061 |
) |
|
|
(41,970 |
) |
Adjusted EBITDA |
$ |
(11,168 |
) |
|
$ |
15,551 |
|
|
$ |
(39,461 |
) |
|
$ |
101,202 |
|
(1) |
Principally included in “Selling, general and administrative” within our unaudited Condensed Consolidated Statements of Operations. |
|
(2) |
Included in “Start-up costs” within our unaudited Condensed Consolidated Statements of Operations and excludes any applicable stock-based compensation, which is included in the “Stock-based compensation expense” line above. Relates to certain costs incurred in connection with the commissioning and starting up of our initial separations capability at |
|
(3) |
Principally included in “Advanced projects and development” within our unaudited Condensed Consolidated Statements of Operations, and pertains to legal, consulting, and advisory services, and other costs associated with specific transactions, including potential acquisitions, mergers, or other investments. |
|
(4) |
Included in “Other operating costs and expenses” within our unaudited Condensed Consolidated Statements of Operations. |
|
(5) |
Amounts for the three and nine months ended |
|
(6) |
Pertains to the gain recognized on the repurchase of |
|
(7) |
Principally comprised of interest and investment income. |
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Adjusted Net Income (Loss) |
|||||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
For the three months
ended |
|
For the nine months
ended |
||||||||||||
(in thousands, unaudited) |
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Net income (loss) |
$ |
(25,516 |
) |
|
$ |
(4,276 |
) |
|
$ |
(43,082 |
) |
|
$ |
40,566 |
|
Adjusted for: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation expense(1) |
|
5,453 |
|
|
|
6,298 |
|
|
|
18,623 |
|
|
|
19,041 |
|
Initial start-up costs(2) |
|
1,493 |
|
|
|
7,082 |
|
|
|
3,918 |
|
|
|
15,474 |
|
Transaction-related and other costs(3) |
|
1,428 |
|
|
|
1,642 |
|
|
|
6,108 |
|
|
|
7,124 |
|
Loss on disposals of long-lived assets, net(4) |
|
420 |
|
|
|
1,087 |
|
|
|
720 |
|
|
|
5,897 |
|
Gain on early extinguishment of debt(5) |
|
— |
|
|
|
— |
|
|
|
(46,265 |
) |
|
|
— |
|
Other |
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
(42 |
) |
Tax impact of adjustments above(6) |
|
(2,912 |
) |
|
|
(4,806 |
) |
|
|
4,816 |
|
|
|
(12,684 |
) |
Adjusted Net Income (Loss) |
$ |
(19,634 |
) |
|
$ |
7,026 |
|
|
$ |
(55,162 |
) |
|
$ |
75,376 |
|
(1) |
Principally included in “Selling, general and administrative” within our unaudited Condensed Consolidated Statements of Operations. |
|
(2) |
Included in “Start-up costs” within our unaudited Condensed Consolidated Statements of Operations and excludes any applicable stock-based compensation, which is included in the “Stock-based compensation expense” line above. Relates to certain costs incurred in connection with the commissioning and starting up of our initial separations capability at |
|
(3) |
Principally included in “Advanced projects and development” within our unaudited Condensed Consolidated Statements of Operations, and pertains to legal, consulting, and advisory services, and other costs associated with specific transactions, including potential acquisitions, mergers, or other investments. |
|
(4) |
Included in “Other operating costs and expenses” within our unaudited Condensed Consolidated Statements of Operations. Amounts for the three and nine months ended |
|
(5) |
Pertains to the gain recognized on the repurchase of |
|
(6) |
Tax impact of adjustments is calculated using an adjusted effective tax rate, which excludes the impact of discrete tax costs and benefits, to each adjustment. The adjusted effective tax rates were 33.1%, 28.5%, 29.8% and 26.7% for the three and nine months ended |
Reconciliation of GAAP Diluted Earnings (Loss) per Share to Non-GAAP Adjusted Diluted EPS |
|||||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
For the three months
ended |
|
For the nine months
ended |
||||||||||||
(unaudited) |
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Diluted earnings (loss) per share |
$ |
(0.16 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.44 |
) |
|
$ |
0.22 |
|
Adjusted for: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation expense |
|
0.04 |
|
|
|
0.03 |
|
|
|
0.11 |
|
|
|
0.10 |
|
Initial start-up costs |
|
0.01 |
|
|
|
0.04 |
|
|
|
0.02 |
|
|
|
0.08 |
|
Transaction-related and other costs |
|
0.01 |
|
|
|
0.01 |
|
|
|
0.04 |
|
|
|
0.04 |
|
Loss on disposals of long-lived assets, net |
|
— |
|
|
|
0.01 |
|
|
|
— |
|
|
|
0.03 |
|
Gain on early extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
(0.27 |
) |
|
|
— |
|
Tax impact of adjustments above(1) |
|
(0.02 |
) |
|
|
(0.03 |
) |
|
|
0.03 |
|
|
|
(0.07 |
) |
2026 Notes if-converted method(2) |
|
— |
|
|
|
— |
|
|
|
0.18 |
|
|
|
— |
|
Adjusted Diluted EPS |
$ |
(0.12 |
) |
|
$ |
0.04 |
|
|
$ |
(0.33 |
) |
|
$ |
0.40 |
|
|
|
|
|
|
|
|
|
||||||||
Diluted weighted-average shares outstanding(3) |
|
164,149,348 |
|
|
|
177,231,717 |
|
|
|
172,066,214 |
|
|
|
193,632,662 |
|
Assumed conversion of 2026 Notes(3) |
|
— |
|
|
|
— |
|
|
|
(4,063,441 |
) |
|
|
— |
|
Assumed conversion of restricted stock(4) |
|
— |
|
|
|
582,144 |
|
|
|
— |
|
|
|
— |
|
Assumed conversion of restricted stock units(4) |
|
— |
|
|
|
438,803 |
|
|
|
— |
|
|
|
— |
|
Adjusted diluted weighted-average shares outstanding(3)(4) |
|
164,149,348 |
|
|
|
178,252,664 |
|
|
|
168,002,773 |
|
|
|
193,632,662 |
|
(1) |
Tax impact of adjustments is calculated using an adjusted effective tax rate, which excludes the impact of discrete tax costs and benefits, to each adjustment. The adjusted effective tax rates were 33.1%, 28.5%, 29.8% and 26.7% for the three and nine months ended |
|
(2) |
For the nine months ended |
|
(3) |
For the nine months ended |
|
(4) |
The assumed conversion of restricted stock and restricted stock units was antidilutive for GAAP purposes for the three months ended |
Conference Call Details
About
Join the
We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investors section of our website. Accordingly, investors should monitor such portion of our website, in addition to following our press releases,
Forward-Looking Statements
This press release contains certain statements that are not historical facts and are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of the words such as “estimate,” “plan,” “shall,” “may,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “will,” “target,” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the price and market for rare earth materials, the continued demand for rare earth materials and the market for rare earth materials generally, future demand for electric vehicles and magnets, estimates and forecasts of the Company’s results of operations and other financial and performance metrics, including NdPr oxide production and shipments, expected NdPr oxide production and sales in the fourth quarter of 2024, the Company’s share repurchase program, the expected cash flows of the early production of magnetic precursor products in Stage III and associated expected magnetic precursor products prepayments and timing thereof, the expected timing for receipt of the 48C tax credits, expected capital expenditures in Stage II and Stage III, the Company’s ability to control costs and expenses, the Company’s Upstream 60K strategy, including statements regarding the timing, costs and ability to increase REO production, and the Company’s Stage II and Stage III projects, including the Company’s ability to achieve run rate production of separated rare earth materials and production of commercial metal and magnets. Such statements are all subject to risks, uncertainties and changes in circumstances that could significantly affect the Company’s future financial results and business.
Accordingly, the Company cautions that the forward-looking statements contained herein are qualified by important factors that could cause actual results to differ materially from those reflected by such statements. These forward-looking statements are subject to a number of risks and uncertainties, including fluctuations and uncertainties related to demand for and pricing of rare earth products; changes in domestic and foreign business, market, financial, political and legal conditions; changes in demand for NdFeB magnets; the effects of competition on the Company’s future business; risks related to the Company’s Upstream 60K strategy, including delays in completion, unexpected costs and expenses and timing for obtaining regulatory approvals; risks related to the rollout of the Company’s business strategy, including Stage II and Stage III, and the timing of achieving expected business milestones in Stage II and Stage III, including the Company’s ability to produce commercial metal in 2024; risks related to the Company’s Stage II operations and the Company’s ability to achieve run rate production of separated rare earth materials; risks related to the Company’s long-term agreement with General Motors, including the Company’s ability to produce and supply NdFeB magnets; risks related to expected sales of separated NdPr oxide due to various risks, including demand and pricing for separated NdPr oxide; risks related to the Company’s ability to develop magnetic precursor products in Stage III, including production delays; risks related to the Company entering into agreements with customers for prepayment of magnetic precursor products, including NdPr metal; risks associated with the terms of the new 3% convertible notes due 2030; risks related to the share repurchase program and whether it will be fully consummated or will enhance long-term stockholder value; the impact of the global COVID-19 pandemic, on any of the foregoing risks; risks related to current and future governmental and environmental laws, regulations, licenses or legal requirements; and those risk factors discussed in the Company’s filings with the
If any of these risks materialize or the assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. The Company does not intend to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this earnings release may not occur.
Use of Non-GAAP Financial Measures
This press release references certain non-GAAP financial measures, including Adjusted EBITDA, Adjusted Net Income (Loss), and Adjusted Diluted EPS, which have not been prepared in accordance with GAAP.
MP Materials’ management uses Adjusted EBITDA, Adjusted Net Income (Loss), and Adjusted Diluted EPS to compare MP Materials’ performance to that of prior periods for trend analyses and for budgeting and planning purposes.
Key Performance Indicators
REO Production Volume is measured in MTs, the Company’s principal unit of sale for its concentrate product. This measure refers to the REO content contained in the rare earth concentrate we produce and, beginning in the second quarter of 2023, includes volumes fed into downstream circuits for commissioning and starting up our separations facilities and for producing separated rare earth products, a portion of which is also included in our KPI, NdPr Production Volume. REO Production Volume is a key indicator of the Company’s mining and processing capacity and efficiency.
REO Sales Volume for a given period is calculated in MTs. A unit, or MT, is considered sold once we recognize revenue on its sale as determined in accordance with GAAP. REO Sales Volume is a key measure of the Company’s ability to convert its concentrate production into revenue. REO Sales Volume includes both traditional concentrate as well as roasted concentrate.
Realized Price per REO MT for a given period is calculated as the quotient of: (i) the Company’s rare earth concentrate sales, which are determined in accordance with GAAP, for a given period and (ii) the Company’s REO Sales Volume for the same period. Realized Price per REO MT is an important measure of the market price of the Company’s concentrate product.
NdPr Production Volume for a given period is measured in MTs, the Company’s principal unit of sale for its NdPr separated products. NdPr Production Volume refers to the volume of finished and packaged NdPr oxide produced at
Our NdPr Sales Volume for a given period is calculated in MTs and on an NdPr oxide-equivalent basis (as further discussed below). A unit, or MT, is considered sold once we recognize revenue on its sale, whether sold as NdPr oxide or NdPr metal, as determined in accordance with GAAP. For NdPr metal sales, the MTs sold and included in NdPr Sales Volume are calculated on the basis of the volume of NdPr oxide used to produce such NdPr metal. We utilize an assumed material conversion ratio of 1.20, such that a sale of 100 MTs of NdPr metal would be included in this KPI as 120 MTs of NdPr oxide-equivalent. NdPr Sales Volume is a key measure of our ability to convert our production of separated NdPr products into revenue. We have a mix of contracts with customers where we sell NdPr as (i) oxide, (ii) metal, where the amount of oxide required to produce such metal is variable, and (iii) metal, where we have a guarantee of the amount produced and sold based on the amount of oxide consumed. Among other factors, differences between quarterly NdPr Production Volume and NdPr Sales Volume may be caused by the time required for the conversion of NdPr oxide to NdPr metal, including time in-transit, as well as differences in actual versus assumed yields of oxide to metal in the calculation of NdPr Sales Volume.
NdPr Realized Price per kilogram (“KG”) for a given period is calculated as the quotient of: (i) our NdPr oxide and metal sales, which are determined in accordance with GAAP, for a given period and (ii) our NdPr Sales Volume for the same period. NdPr Realized Price per KG is an important measure of the market price of our NdPr products.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241107341825/en/
Investors:
IR@mpmaterials.com
Media:
Matt Sloustcher
media@mpmaterials.com
Source: